KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueTax ProvisionsTax Rate
Others
Ratios

HCA Healthcare (HCA) EBITDA (2016 - 2025)

Historic EBITDA for Healthcare (HCA) over the last 16 years, with Q4 2025 value amounting to -$1.4 billion.

  • Healthcare's EBITDA rose 1867.82% to -$1.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$6.1 billion, marking a year-over-year increase of 384.37%. This contributed to the annual value of $5.6 billion for FY2025, which is 961.84% up from last year.
  • Latest data reveals that Healthcare reported EBITDA of -$1.4 billion as of Q4 2025, which was up 1867.82% from -$1.7 billion recorded in Q3 2025.
  • Over the past 5 years, Healthcare's EBITDA peaked at $627.0 million during Q3 2021, and registered a low of -$1.8 billion during Q3 2024.
  • Its 5-year average for EBITDA is -$1.0 billion, with a median of -$1.2 billion in 2023.
  • In the last 5 years, Healthcare's EBITDA skyrocketed by 82244.9% in 2022 and then plummeted by 36858.41% in 2023.
  • Healthcare's EBITDA (Quarter) stood at $49.0 million in 2021, then soared by 822.45% to $452.0 million in 2022, then plummeted by 368.58% to -$1.2 billion in 2023, then crashed by 43.33% to -$1.7 billion in 2024, then grew by 18.68% to -$1.4 billion in 2025.
  • Its EBITDA stands at -$1.4 billion for Q4 2025, versus -$1.7 billion for Q3 2025 and -$1.4 billion for Q2 2025.